Key result
Aggressive diuresis and guideline-directed therapy resolves severe congestive hepatopathy and ascites in HFpEF.
Why the study?
Congestive hepatopathy is an underrecognized manifestation of elevated cardiac filling pressures and systemic venous congestion in heart failure.
Case Report (n=1)
Preserved systolic function does not exclude severe extracardiac congestion, including congestive hepatopathy and cardiac ascites, which can mimic primary hepatobiliary disease but respond to aggressive decongestion.
Answers are grounded in this paper and cite their sources.
May warrant cardiac evaluation for unexplained hepatopathy; hypothesis-generating for HFpEF congestion management, requires confirmation.
Congestive hepatopathy is an underrecognized manifestation of elevated cardiac filling pressures and systemic venous congestion in heart failure. Although acute decompensated heart failure often presents with pulmonary edema and respiratory compromise, advanced diastolic dysfunction may also produce hepatic congestion, ascites, pleural effusions, and cardiorenal syndrome. We present the case of a 48-year-old male with hypertension, hyperlipidemia, type 2 diabetes mellitus, and recently diagnosed heart failure with preserved ejection fraction (HFpEF) who presented with progressive dyspnea, orthopnea, bilateral lower extremity edema, and declining exercise tolerance. Laboratory evaluation demonstrated hypervolemic hyponatremia, acute kidney injury, hyperbilirubinemia, and cholestatic-predominant liver injury. Echocardiography revealed preserved ejection fraction with severe concentric left ventricular hypertrophy and findings suggestive of elevated right-sided filling pressures, including a dilated inferior vena cava with reduced inspiratory collapse. Left heart catheterization demonstrated significantly elevated left ventricular end-diastolic pressure despite nonobstructive coronary artery disease. Abdominal imaging showed hepatomegaly, ascites, mesenteric congestion, pleural effusion, and gallbladder wall thickening without biliary obstruction. The patient improved with aggressive intravenous diuresis and guideline-directed therapy. The combined clinical, laboratory, imaging, hemodynamic, and treatment-response findings were most consistent with congestive hepatopathy and cardiac ascites due to severe systemic venous congestion. Preserved systolic function does not exclude severe extracardiac congestion, including hepatic congestion, ascites, and cardiorenal syndrome. Recognizing congestive hepatopathy can prevent unnecessary hepatobiliary evaluation and direct appropriate hemodynamic management and decongestion.
No takes yet. Share an insight, caveat, or question.
Masi et al. (2026) conducted a case report in Cardiohepatic syndrome in HFpEF (n=1). Intravenous diuresis and guideline-directed medical therapy was evaluated on Clinical and laboratory improvement. Aggressive intravenous diuresis and guideline-directed therapy improved severe systemic venous congestion, congestive hepatopathy, and cardiac ascites in a patient with HFpEF.
Synapse has enriched 10 related papers. Consider them for comparative context: